Trexquant Investment LP Makes New Investment in Mettler-Toledo International Inc. (NYSE:MTD)

Trexquant Investment LP purchased a new stake in Mettler-Toledo International Inc. (NYSE:MTDFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 4,985 shares of the medical instruments supplier’s stock, valued at approximately $6,100,000.

A number of other institutional investors also recently modified their holdings of MTD. SBI Securities Co. Ltd. acquired a new position in Mettler-Toledo International during the fourth quarter worth about $33,000. Edmond DE Rothschild Holding S.A. acquired a new position in Mettler-Toledo International during the 4th quarter worth approximately $44,000. Blue Trust Inc. increased its position in Mettler-Toledo International by 70.8% during the 4th quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier’s stock worth $50,000 after purchasing an additional 17 shares in the last quarter. Whipplewood Advisors LLC bought a new position in Mettler-Toledo International in the 4th quarter valued at approximately $54,000. Finally, Sound Income Strategies LLC boosted its position in Mettler-Toledo International by 4,500.0% in the fourth quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock valued at $56,000 after buying an additional 45 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Down 6.7 %

MTD opened at $1,021.97 on Friday. Mettler-Toledo International Inc. has a twelve month low of $1,000.72 and a twelve month high of $1,546.93. The company has a fifty day moving average of $1,264.13 and a 200-day moving average of $1,295.07. The stock has a market cap of $21.30 billion, a PE ratio of 25.22, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Sell-side analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the transaction, the insider now owns 6 shares in the company, valued at $8,108.04. The trade was a 99.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on MTD. Wells Fargo & Company increased their price target on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. Citigroup cut their price target on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Robert W. Baird upped their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Wolfe Research began coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. Finally, Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and a consensus target price of $1,380.50.

View Our Latest Analysis on MTD

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.